Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Atyr Pharma Inc (NQ: LIFE ) 1.900 UNCHANGED Last Price Updated: 4:00 PM EDT, Jun 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 1.900 Bid (Size) 1.900 (15) Ask (Size) 1.950 (20) Prev. Close 1.900 Today's Range 1.900 - 1.900 52wk Range 1.080 - 2.150 Shares Outstanding 54,291,754 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025 June 05, 2024 These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real. Via InvestorPlace aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR” June 03, 2024 Ticker symbol change to take effect on Wednesday, June 5, 2024 From aTyr Pharma, Inc. Via GlobeNewswire Performance YTD +27.09% +27.09% 1 Month N/A N/A 3 Month N/A N/A 6 Month +14.46% +14.46% 1 Year +46.15% +46.15% More News Read More aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 24, 2024 From aTyr Pharma, Inc. Via GlobeNewswire Recap: aTyr Pharma Q4 Earnings March 14, 2024 Via Benzinga aTyr Pharma's Earnings Outlook March 13, 2024 Via Benzinga Analyst Expectations for aTyr Pharma's Future September 21, 2023 Via Benzinga aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference May 15, 2024 From aTyr Pharma, Inc. Via GlobeNewswire aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis May 14, 2024 From aTyr Pharma, Inc. Via GlobeNewswire aTyr Pharma to Present at Upcoming Investor Conferences May 06, 2024 From aTyr Pharma, Inc. Via GlobeNewswire LIFE Stock Earnings: aTyr Pharma Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 Via InvestorPlace aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update May 02, 2024 From aTyr Pharma, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session April 09, 2024 Via Benzinga aTyr Pharma to Participate in April Investor Conferences April 01, 2024 From aTyr Pharma, Inc. Via GlobeNewswire 3 Penny Stocks That Could Be Multibaggers in the Making: March Edition March 26, 2024 Via InvestorPlace LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023 March 14, 2024 Via InvestorPlace aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update March 14, 2024 From aTyr Pharma, Inc. Via GlobeNewswire aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results February 28, 2024 From aTyr Pharma, Inc. Via GlobeNewswire Earnings Scheduled For March 14, 2024 March 14, 2024 Via Benzinga aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants February 21, 2024 From aTyr Pharma, Inc. Via GlobeNewswire The 3 Best Penny Stocks to Buy in February 2024 February 15, 2024 Via InvestorPlace aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity January 29, 2024 From aTyr Pharma, Inc. Via GlobeNewswire aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor January 18, 2024 From aTyr Pharma, Inc. Via GlobeNewswire Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition! November 13, 2023 Via IssueWire Topics Religion Exposures Religion aTyr Pharma to Present at November Investor Conferences November 01, 2023 From aTyr Pharma, Inc. Via GlobeNewswire aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD October 31, 2023 From aTyr Pharma, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
